ArticleCancer biology & therapy2025

SLX1 silencing overcomes Olaparib resistance in metastatic castration-resistant prostate cancer by disrupting SLX4-mediated DNA repair complexes.

Xin Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.